www.cancer-genetics.org |
|
| Disclaimer: This site is for educational purposes only; it can not be used in diagnosis or treatment. | |
Mutated Genes and Abnormal Protein Expression
| ||
| Gene | Location | Topics |
| PAX7 | 1p36.2-p36.12 | |
| MYCN ( NMYC , N-MYC ) | 2p24.1 |
-MYCN Amplification in Rhabdomyosarcoma |
| PAX3 ( WS1 , HUP2 ) | 2q35 | |
| CDKN2B ( P15 , INK4B ) | 9p21 |
-CDKN2B and Rhabdomyosarcoma |
| CDKN2A ( P16 , INK4A , MTS1 ) | 9p21 |
-CDKN2A and Rhabdomyosarcoma |
| SLC22A1L ( BWSCR1A , ORCTL2 , IMPT1 ) | 11p15.5 |
-SLC22A1L and Rhabdomyosarcoma ? |
| ETV6 ( TEL ) | 12p13 |
-t(12;15)(p13;q25) in Congenital Fibrosarcoma |
| MDM2 | 12q13-q14 |
-MDM2 and Rhabdomyosarcoma |
| CDK4 ( PSK-J3 ) | 12q14 |
-CDK4 and Rhabdomyosarcoma |
| FKHR ( FKH1 ) | 13q14.1 |
-FKHR and Rhabdomyosarcoma -t(2;13)(q35;q14) in Rhabdomyosarcoma -t(1;13)(p36;q14) in Rhabdomyosarcoma |
| TP53 ( p53 , P53 ) | 17p13.1 |
-TP53 and Rhabdomyosarcoma |
| ||
Recurrent Chromosome Abnormalities
| ||
|
Overview of the Molecular Biology of Rhabdomyosarcoma
| |||||
|